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Background: Colorectal cancer is a major public health problem in Malaysia. However, it is also one of the most
treatable cancers, resulting in significant numbers of survivors. Therefore, the impact of surviving treatment for
colorectal cancer on health related quality of life is important for the patients, clinicians and policy makers, and may
differ in different cultures and populations. The aim of this study was to validate the Malaysian versions of the
European Organization for Research and Treatment of Cancer quality of life instruments among colorectal cancers
patients.
Methods/design: This is a cross sectional multi centre study. Three hospitals were included, the University of
Malaya Medical Centre, the Universiti Kebangsaan Malaysia Medical Centre and Hospital Tuanku Jaafar Seremban.
Malaysian citizens and permanent residence were studied and demographic and clinical information obtained from
hospital records. The European Organization for Research and Treatment of Cancer Quality of life Core 30, colorectal
cancer CR29, and the colorectal cancer liver metastasis LMC 21 were used and an observer assessment of
performance obtained with the Karnofsky Performance Scale. Questionnaires were translated into three most
commonly spoken languages in Malaysia (Bahasa Malaysia, Chinese and Tamil), then administered, scored and
analyzed following the developers’ guidelines. Ethical approval was obtained from the participating centres. Tests of
reliability and validity were performed to examine the validity of these instruments.
Conclusion: The result of pilot testing shows that the use of the Malaysian versions of EORTC QLQ C30, CR29
instruments is feasible in our sample of colorectal cancer patients. Instructions for completion as well as questions
were well understood except the questions on the overall quality of life, overall health status and sexual activity.
Thus we anticipate obtaining good psychometric properties for the instruments at the end of the study.
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Colorectal cancer is a major public health problem in Ma-
laysia. Colon cancer ranked third among cancers reported
in males and females, accounting for 7.8% and 5.6% in
males and females respectively. Cancer of the rectum
ranked fifth and eighth among cancers reported in males
and females respectively. This disease accounted for 6.4%
and 3.4% in males and females respectively. When taken
together, colorectal cancers would account for 14.2% of
male cancers making it the commonest cancer among* Correspondence: drmagaji@siswa.um.edu.my
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reproduction in any medium, provided the ormen and 10.1% of female cancers the third most common
cancer among women [1].
Conventional outcome measures focus on disease-
centric criteria, such as complications or survival. How-
ever, the impact of treatments on patient wellbeing is
rarely assessed, even though it may be just as significant
if not more so. Studies on Health -related quality of life
(HRQoL) is complementary to the traditional medical
assessments rather than a standalone way of assessing
well-being [2,3].
In assessing HRQoL it is important to use a valid meas-
urement tool [4,5]. There are valid instruments that
are in use presently, for example the Functional Assess-
ment of Cancer Therapy consists of a core instrument
(FACT-G) and its various sub-scales such as the FACT-CLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pean Organization for Research and Treatment of Can-
cer (EORTC), Quality of Life (QLQ) core questionnaire
EORTC QLQ-C30 and several other modules. With re-
spect to colorectal cancer, EORTC developed a colorectal
cancer specific module EORTC QLQ-CR 29 and colorec-
tal cancer liver metastasis module EORTC QLQ-LMC
21. However, in many cases, the validity and cultural con-
text underlying developing such instruments are those of
the original language and cultural setting [5,7]. This lim-
its the direct application of such instruments. This brings
about the need for translation and validation of these
tools to suit the local needs and languages barriers. So far
these questionnaires have been translated and validated
in Europe and other parts of the world. However, such
instruments are yet to be validated in Malaysia.
Therefore, this study aimed to validate the translated
Malaysian versions of the EORTC QLQ-C30, EORTC
QLQ-CR29 (version 2.1) and colorectal cancer liver me-
tastasis EORTC QLQ-LMC21 instruments for health
related quality of life measurement among colorectal
cancer patients.
Objectives
Our objective is to validate a Bahasa Malaysia, Chinese
(Malaysia) and Tamil (Malaysia) versions of colorectal
cancer disease EORTC QLQ-CR29 (version 2.1) and
colorectal cancer liver metastasis EORTC QLQ-LMC21
instruments for health related quality of life measurement.
Methods
Setting
This is a multi-center study, involving three hospitals in
Malaysia. The selected hospitals are University of Malaya
Medical Centre (UMMC), Universiti Kebangsaan Malay-
sia Medical Centre (UKMMC) and Hospital Tuanku Jaa-
far, Seremban (HTJS).
Study population (inclusion or exclusion)
The study includes Malaysian citizens or permanent
residents with histologically confirmed colon or rectal
cancers. They should be receiving or planned to receive
at least one form of treatment at the medical centers.
Excluded patients are those aged less than 18 years,
those with incomplete diagnosis and those with language
problem or inability to understand any of the three lan-
guages of the instruments.
Ethical issues
This study was approved by the ethics committees of the
UMMC (MEC Ref.No:770.2), UKMMC (Project code:
FF-274-2011) and the Ministry of Health Malaysia for
using Hospital Tuanku Jaafar Seremban (NMRR-11-348-
9245). The project was also under the guidance of theEORTC QOL office. We obtained written, informed
consent from each participant as recommended by the
ethics of medical research.
Study variables
A data extraction form was developed for the purpose of
gathering the relevant demographic and clinical data
from the hospital records. Variables collected were:
patient’s identification number, age, sex, race, marital
status, nationality, educational status, employment status
and cohabitation. Information on the index cancer was:
site of primary cancer (according to the IARC and UICC
cancer classification manual 8th edition), tumour stage
(Dukes), and histopathological differentiation. Treatment
planned or received such as; surgery, presence or ab-
sence of stoma, chemotherapy and radiotherapy.
Research tools
The instruments selected for this study include a ‘core’
instrument EORTC QLQ-C30 (version 3.0) and two
other ‘modules’, for colorectal cancer EORTC QLQ-
CR29 and colorectal cancer liver metastasis (LMC 21)
respectively. The choice of these instruments was guided
by the availability, established psychometric properties,
and non-superiority of other instruments [7,8]. The
QLQ-C30 is one of the most widely used instruments in
cancer clinical research [8]. EORTC QLQ-CR29 is the
newest version of the colorectal cancer specific QoL
questionnaire recently validated in Europe [9]. The
QLQ-LMC21 is the only liver metastasis specific instru-
ment in use at present [10]. A Karnofsky Performance
Scale was used by the clinicians to rate the well-being of
the patients [11].
Sample size estimation
1. Pilot study: according to the EORTC QOL group,
each translated item of the questionnaire should be
pilot-tested on 10 to 15 subjects before being field-
tested on a larger sample [12]. So for each of the two
set of questionnaires: EORTC QLQ-CR29 and
LMC21, we have included 30 subjects, ten each for
Bahasa Malaysia, Chinese and Tamil respectively
1. 2. Validation: For a multivariate analysis technique to
gain reliable estimates, the number of subjects’
observations should be 10 times the number of
variables in the model [13]. Therefore, the sample
size was estimated based on this recommendation as
follows;a) EORTC QLQ-CR29: There are 29 items in the
CR29. Thus the minimum number of subject
required is 290. In our study, we use 300 subjects
to account for possible attrition.
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contains 21 items; therefore, we need a minimum
of 210 subjects for its validation.Procedure
Research assistants
Three research assistants aided in data collection. Each
assistant could read and speak a minimum of two lan-
guages from the three languages used in this study.
Patient’s identification
Prospective patients were identified using the eligibility
criteria above. Eligible subjects received an invitation let-
ter and/or telephone calls at least two weeks before their
next visit to the clinic.
Baseline data and Karnofsky Performance Scale
Baseline data for all prospective patients were obtained
from the medical records using a data extraction form
mentioned above. Missing data was obtained from the
patients during the interview. The clinician completed
the Karnofsky Performance scale during patient’s visit on
the same day as the day of the interview.
Questionnaire administration
Personal characteristics such as sexual behavior and fam-
ily life are better assessed through a self-administered
method. It has the advantages of being reliable, preferred,
in HRQoL studies and also cheap to undertake [5]. The
data collection method was self-administered and inter-
viewer delivered the research administrators (research
assistants and the researcher) presented the instruments,
answered questions from respondents and were present
throughout the sessions. This gave further motivation to
the patients and encouraged them to answer every item.
The reliability and quality in the answer were therefore
ensured.
Pilot study
In preparation for the pilot study, we translated the
chosen tools into three main Malaysian languages based
on the recommendations contained in the EORTC QoL
group translation procedure [13].
The aim of pilot testing is to identify any potential
problems in the translation of the instruments. Attention
was on the following six areas; acceptability (face valid-
ity), clarity of the introduction and instructions, com-
pleteness, linguistic clarity, spontaneity of response and
practicality of using the instruments. Interviews were
conducted and it covered the following areas: difficulty
in answering the questions, confusion, difficult words,
upsetting nature, and an open comment on how the pa-
tient would ask a similar question if given opportunity.
Responses were recorded and reported.Subject grouping and assessment plan
Eight groups of patients were examined. These were
adopted and modified from the EORTC QLQ-CR29 val-
idation study in Europe [9].
a) Group 1: patients with colon cancers, had surgery
with no stoma, not receiving any form of
chemotherapy. This group was being assessed once
and the questionnaires were completed within
12 months of surgery.
b) Group 2: patients with colon cancers, had surgery
with no stoma, receiving any form of chemotherapy.
This group was being assessed once and the
questionnaires were completed within 12 months of
surgery but within two weeks of receiving
chemotherapy.
c) Group 3: Rectal cancer patients with preoperative
radiotherapy, the questionnaires were completed
within two weeks of the radiotherapy.
d) Group 4: Patients with a permanent stoma;
irrespective of the cancer site. This group was being
assessed within five years post-surgery.
e) Group 5: Temporary stoma patients; irrespective of
the cancer site. This group was being assessed twice,
within one month after surgery with stoma, and
within one to three months after closure of the
stoma.
f ) Group 6: Palliative care group: these were patients
who were being treated with palliative intention.
They were being assessed twice, first within two
weeks of receiving chemotherapy or radiotherapy
and second assessment was performed three months
after the first assessment.
g) Group 7: Test-retest group; these patients were
selected randomly from the six groups above and
they were requested to complete the questionnaires
within 7–14 days after the first assessment.
h)Group 8: Liver metastasis group; these patients were
required to complete the questionnaires once.
Statistical analysis
Data preparation
Questionnaires were checked and data entered into a
database in Microsoft Excel and later transferred to SPSS
version 20.0 for Windows for analysis. Data coded based
on the guidelines as contained in the EORTC scoring
manual [14]. Two-sided tests were used, and p-values
of ≤ 0.05 were considered statistically significant.
Descriptive statistics
Descriptive statistical analysis was performed for all vari-
ables. Continuous variables were reported using means
and standard deviations or median and inter-quartile
range. For dichotomous variables, absolute numbers and
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taken to complete the questionnaires were assessed [15].
Confirmatory factor analysis was performed.
Psychometric properties
Multitrait scaling analysis
Multitrait scaling analysis was employed to examine
item convergent validity. Each items scale’s Pearson’s
product moment correlation should exceed 0.4 for con-
vergent validity on all scales. Inter scale correlations
were used to measure discreminant validity which was a
measure of item own scale correlation in relation to
other scales. It is hypothesized item own correlation
should be higher than with the other scales.
Internal consistency reliability
The internal consistency was assessed using the cron-
bach’s alpha coefficient. Coefficients of above 0.70 were
considered acceptable for group comparisons.
Reproducibility (test-retest reliability)
Intraclass Correlation Coefficient (ICC) was used to as-
sess the test-retest reliability. A score of one indicates
perfectly reliable, zero perfectly unreliable test.
Group comparisons
Subjects were compared based on the treatment groups
such as subjects receiving chemotherapy, versus surgery
alone, patients with and without stoma and performance
status (KPS score of ≤ 80% versus ≥ 81%). Non parametric
test Wilcoxon rank sum test were used for the compari-
son of the groups.
Responsiveness
Responsiveness was measured by comparing changes
over time of the instruments in subgroup of patients
undergoing palliative chemotherapy (Group 6) and after
closure of a temporary stoma (Group 4).
Instrument acquisition and pilot testing
This study was designed to validate three EORTC ques-
tionnaires on a sample of colorectal cancer patients in
Malaysia. The questionnaires included were; EORTC
QLQ-C30 (version 3.0), EORTC QLQ CR29 and EORTC
QLQ LMC21.
Questionnaires were acquired from the relevant devel-
opers and EORTC Quality of life group. Translation was
performed according to the group guidelines; pilot test-
ing was conducted and reported below. The validation
testing is ongoing.
Pilot testing
Pilot testing was conducted from January 02, 2012 to
January 31, 2012. Questionnaires were administered to10 patients for Bahasa Malaysia and 10 patients for
Chinese-Malaysia versions. Due to inadequate number
of patients suitable for QLQ LMC21 questionnaire and
the Tamil version of all three questionnaires, we decided
to remove them from our study.
Patients’ characteristics
Details of the Socio demographic and clinical character-
istics of the patients were presented in Table 1.0 for
Bahasa Malaysia and Chinese-Malaysia.
Bahasa-Malaysia version
Mean age was 58 ± 12 years, Male: Female ratio 1:1, 30%
had attained tertiary education, 60% had rectal cancer
followed by sigmoid 30% and recto sigmoid 10% respect-
ively. 50% had stoma, 70% chemotherapy and 60% had
radiotherapy. Karnofsky performance status was ≥80 in
90% of patients.
Chinese-Malaysia version
Mean age was 67 ± 8 years, Male: Female ratio 1:1, 70%
had attained tertiary education, rectal cancer 30%, recto
sigmoid, ascending and transverse colon each 20% re-
spectively. 50% had stoma, 60% chemotherapy and 40%
had radiotherapy. Karnofsky performance status was ≥80
in 50% of patients.
Main Findings
There was no difficulty in understanding the introduc-
tion as well as the instructions for completion of the
questionnaire. Mean duration for completion of a set
was found to be 8 ± 2 minutes.
Patients consider the time of administration which was
immediately after the consultation with the doctors to be
inappropriate. Questionnaire items 1–28, 31–54 were not
associated with any difficulty in answering, nor were they
confusing, difficult to understand or offensive. Questions
29–30 and 56–59 were associated with some problems.
Questions 29 &30 are questions about the overall quality
of life and general health status. Three patients answering
Bahasa-Malaysia versions indicated their difficulty in dif-
ferentiating between question 29 & 30. They considered
the duo to mean the same and suggested the questions
to be merged. Questions 56 to 59 are questions about
the sexual activities. (Questions 56–57 are for male and
58–59 are for female patients respectively). Three
patients (Bahasa-Malaysia version) and five patients
(Chinese-Malaysia version) felt the questions were not
necessary because they were no more sexually active.
Discussion
The pilot testing showed that the use of the Malaysian
translated versions of EORTC QLQ C30, CR29 instru-
ments is feasible in our sample of colorectal cancer
Table 1 Socio demographic and clinical characteristics of
patients included in the pilot testing of the EORTC QLQ-
CR29 (Bahasa-Malaysia and Chinese-Malaysia)
Variable Bahasa-Malaysia Chinese-Malaysia
N (%) N (%)
Age (years)









Full time 4(40) 9(90)
Retired 6(60) 1(10)
Tumour site
Ascending colon - 2(20)
Transverse colon - 2(20)
Splenic flexure - 1(10)
Sigmoid 3(30) -
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were well understood except the questions on the overall
quality of life, overall health status and sexual activity.
The use of self-administered interviewer delivered
method of data collection was a good way to address this
problem. Timing of administration was of major concern.
We therefore, opted for another approach which was to
ask the patients to complete the questionnaire while wait-
ing for their turn to see doctor(s) as opposed to the initial
method of administering the questionnaire after the
consultation.This study is the first of its kind among colorectal
cancer patients in Malaysia. Previous studies in China,
Taiwan and Singapore indicated good psychometric
properties for the standard Chinese versions and English
versions of the EORTC QLQ C-30 AND CR38 instru-
ments respectively. [16-20]. The current version of the
EORTC QLQ-CR29 underwent a number of validation
studies since it was first developed and validated in Eur-
ope in 2009[9]. Such validation studies indicate an excel-
lent psychometric property [21-23]. Interestingly, there
was no such validation in Malaysia or its neighbors such
as Singapore, Thailand or Brunei which might render
this study unnecessary. We acknowledge one previous
study involving the validation of Malay version of
EORTC QLQ-C30 among breast cancer patients and a
subsequent study using such instrument validated
among breast cancer patients to study the quality of life
of colorectal cancer patients.
Our initial plan was to study the psychometric proper-
ties of the instruments among the three commonly
spoken languages in Malaysia that are Bahasa Malaysia,
Chinese-Malaysia and Tamil-Malaysia. However, findings
from the pilot testing indicated that there was inad-
equate number of patients that were able to read and
write in the Tamil language. This might be due to the
fact that colorectal cancer is not as common among the
Indian patients as compared to Chinese and Malay
patients. In addition, most of the Malaysian Indian
population does not receive their education from Tamil-
medium school. In view of this, we had to give up on
the Tamil questionnaires in this study.
The number of colorectal cancer patients with liver
metastasis was not many. Out of these patients, quite a
significant number of them were not operable; hence
shorten their survival Thus we decided to drop these
QLQ LMC21 questionnaires in this study.
Further studies are therefore recommended for the
validation of the liver metastasis through a prospective/
longitudinal study involving a large number of hospitals
across Malaysia. Also we recommend the use of the
instruments (if found to be valid and reliable) for studies
in the feasibility of its application in day to day clinical
follow up, also to generate a reference values for Malay-
sian colorectal cancer patients that will be useful in fu-
ture policy and research purposes.
In conclusion, it is clear that the use of the Malaysian
versions of EORTC QLQ C30, CR29 instruments is feas-
ible in our sample of colorectal cancer patients. Instruc-
tions for completion as well as questions were well
understood except the questions on the overall quality of
life, overall health status and sexual activity. We anticipate
that once the validation is completed, it would provide
adequate information on the psychometric properties of
the Malaysian versions of the EORTC QLQ-C30 and
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ture, this validated instrument would be very useful in
complementing the routine clinical practice involving
colorectal cancer patients.
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